Background: Infants born to mothers with opioid use disorder (OUD) and prenatally treated with buprenorphine have a significantly lower incidence of neonatal opioid withdrawal syndrome (NOWS), its treatment duration, and hospital length of stay compared with methadone. However, risk of NOWS remains and clinicians continue to lack an objective methodology to predict NOWS severity among these infants.
Objective: The purpose of this study was to assess the relationship between buprenorphine exposure, umbilical cord tissue (UCT) concentrations, and NOWS development and severity.
Methods: A single-center retrospective observational cohort study from March 2018 through June 2020 of newborns exposed to buprenorphine in utero. Associations between quantified buprenorphine exposure, neonatal UCT concentrations, NOWS diagnosis, and severity were made using regression analyses.
Results: A total of 24 mothers and 25 neonates were included. Length of maternal buprenorphine therapy (months) positively correlated to norbuprenorphine ( = 0.234, = 0.019) and buprenorphine + norbuprenorphine UCT concentrations ( = 0.203, = 0.031). A positive relationship was seen between active metabolite concentrations and cumulative morphine dose (mg/kg) for treatment of severe NOWS ( = 0.471, = 0.007). A 0.36 ng/g buprenorphine + norbuprenorphine UCT (CI = 0.002-0.72, = 0.049) equated in a 1-point increase in modified peak Finnegan score.
Conclusion And Relevance: Buprenorphine and norbuprenorphine UCT concentrations can allow for quantification of in utero fetal exposure and demonstrate an association with a longer duration of exposure with the severity and treatment of NOWS in exposed infants.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1177/10600280221134643 | DOI Listing |
Chemosphere
December 2024
University of Chemistry and Technology (UCT), Prague, Faculty of Food and Biochemical Technology, Department of Food Analysis and Nutrition, Technicka 5, 166 28, Prague, Czech Republic.
This study investigates the presence of perfluoroalkyl substances (PFAS) in the drinking water supplies in the Czech Republic using a risk-based monitoring approach. Tap water samples (n = 27) from sources close to areas potentially contaminated with PFAS were analysed. A total of 28 PFAS were measured using ultra-performance liquid chromatography with tandem mass spectrometry after solid phase extraction.
View Article and Find Full Text PDFMar Pollut Bull
December 2024
Laboratorio de Ecotoxicología y Monitoreo Ambiental, Departamento de Ciencias Ambientales, Facultad de Recursos Naturales, Universidad Católica de Temuco, Casilla 15-D. Rudecindo Ortega, 02950. Temuco, Chile.
The Ventanas copper smelter began its activities in Quintero Bay in 1960, and it is estimated that it has released around 152 tons of copper per year into the waters of the bay since then. The increasing copper concentrations in the sediments exceed international standards and pose a potential danger for marine fauna. The object of this work carries out a present and historical ecological risk assessment of copper concentrations in the marine sediment of Quintero Bay.
View Article and Find Full Text PDFInt J Legal Med
December 2024
Division of Forensic Medicine and Toxicology, Department of Pathology, Faculty of Health Sciences, University of Cape Town, Anzio Road, Cape Town, South Africa.
Adverse drug reactions and fatalities can result from therapeutic drug use due to genetic deficiencies in drug-metabolizing enzymes. In cases where ancillary testing may not reveal a clear cause of death, molecular autopsies can be valuable. However, forensic mortuaries do not retain DNA samples in all cases, which hinders subsequent genetic testing if it is later deemed necessary.
View Article and Find Full Text PDFJ Pharm Biomed Anal
December 2024
Division of Clinical Pharmacology, Department of Medicine, University of Cape Town, Cape Town, South Africa. Electronic address:
For the effective treatment of tuberculosis with first-line anti-tubercular drugs, drug concentrations need to be measured at the site of infection to determine drug exposure. To enable the measurement of the anti-tuberculosis drugs isoniazid and pyrazinamide in the nervous system of patients with tuberculous meningitis, an analytical method was developed and validated for the quantification of these drugs in human cerebrospinal fluid. Samples were prepared by solid phase extraction using Strata-X polymeric extraction plates.
View Article and Find Full Text PDFJ Clin Med
November 2024
Department of Internal Diseases, Allergology, Endocrinology and Gastroenterology, Institute of Medical Sciences, University of Opole, 45-040 Opole, Poland.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!